In a pre-Series A funding round headed by Turbostart, health tech startup Ai Health Highway has raised $1 million. In addition to notable investors like Rainmatter by Zerodha, The Chennai Angels, BITS BioCyTiH Foundation, and other angel investors, this investment is a part of a larger $1.5 million funding round.
Ai Health Highway said in a press release that the money will be used to strengthen its position in India, quicken regulatory clearances abroad, and expand its AI/ML services in the cardio-respiratory space.
Ai Health Highway, founded in 2018 by Satish Jeevannavar, is dedicated to offering tech-enabled screening tools that support the early detection of non-communicable diseases (NCDs) and enhance accessibility to healthcare through its AI-enabled stethoscope, AiSteth. By 2030, the company wants to see a 30% decrease in NCD-related premature deaths worldwide.
Ai Health Highway claims that AiSteth enhances cardiac care by helping medical professionals and non-specialists understand cardiac sounds in order to facilitate informed clinical judgments. It makes use of cutting-edge artificial intelligence (AI) and signal processing to turn conventional stethoscopes into effective screening instruments that can identify potentially fatal cardiac conditions early on.
Enhancing the accessibility and affordability of healthcare solutions, the AI-enabled stethoscope seamlessly integrates into current workflows, providing primary care providers with superior heart sound capture, analysis, and data-sharing capabilities.
